Clinical
Contract Research Organization (CRO)

Transforming clinical data into reliable evidence

The Clinical Challenges We Address

Life science companies must prove that every therapy or medicine offers a clear benefit–risk balance and tangible value to patients and health systems.

Regulators demand patient-level evidence that ties pre-clinical promise to clinical benefit, confirms safety and real-world performance, and supports post-market surveillance and reimbursement.

Stricter rules – ICH GCP E6(R3), EU MDR/IVDR, updated FDA guidances – plus decentralized trials and heterogenous data sources have made studies more complex and heightened operational risk. Limited specialist talent and tighter budgets clash with compressed timelines, where a single protocol deviation, data lapse, or site delay can jeopardize approval and investor confidence. Only CROs that unite scientific rigour, digital acceleration, and anticipatory regulatory insight can steer products from first-in-human trials to sustained evidence generation.

Our Approach

Efor’s CRO embeds scientific rigour and a risk-based, data-driven mindset throughout the study lifecycle. Acting as a partner rather than a proxy, we protect sponsor and patient interests. Therapeutic-area experts design protocols with clinically meaningful endpoints, while data managers and bio statisticians ensure the quality and interpretability of all collected patient data. By using real-time oversight, adaptive monitoring and proactive quality analytics, our teams streamline workflows, boost quality and ensure audit-proof documentation at every milestone.

Our Services

Efor delivers flexible clinical-trial support across all life-science sectors, including pharma, biotech, medical devices, IVDs, cosmetics, and consumer health. Whether you need a complete clinical CRO solution, functional service provision, turnkey deliverables, or focused consulting and training, we tailor our services to your project’s precise scope and geographic requirements.

Scientific & Medical Affairs

Strategic evidence‐generation consulting
Regulatory gap analysis,
Protocol / synopsis / endpoint / CRF
Full-spectrum medical writing (IB review
CSRs
Manuscripts
Abstracts
Posters
Systematic literature review, etc.

Clinical Operations

Trial management (Phase I–IV, feasibility to post-market)
Regulatory submission
Site selection and qualification
Start-up and contracting
Investigator engagement
On-site / remote / risk-based monitoring
Vendor oversight
TMF management

Data Management & eClinical Solutions

EDC / ePRO / eCRF design & validation
CDISC-compliant data architecture (CDASH, SDTM)
Real-time quality checks
Discrepancy management
Medical coding
Database lock
Data archiving
Secure data transfer with dedicated tools

Biostatistics & Statistical Programming

Study design consultation
Sample-size calculations
Randomization
SAP development
TLF specification
Interim & final analyses
ADaM dataset creation
PK/PD modelling
Adaptive design simulations.

These services are enriched by a versatile data team covering also Bioinformatics and Biostatistics for multi-Omics data at Data Scientists for complex data integration: signal processing, medical imaging, NLP, wearables and sensors, etc.

Clinical & Performance Evaluation (MD / IVD)

Clinical/Performance evaluation strategy & plan
Data appraisal
Literature review & benchmark
GSPR conformity assessment
Clinical evaluation report
Performance evaluation report
PMCF/PMPF study design and execution
SSCP/SMP writing
Non-conformity remediatio

Post-Market Evidence & Real-World Data

PASS/PAES studies
Registries and real-world evidence generation
Benefit–risk monitoring for each product and medicine

Why Efor?

Integrated into Efor Group since 2021, our clinical CRO brings more than 30 years of operational excellence to the design and conduct of your clinical trials – and to the analysis of patient data. Harmonised SOPs embed quality in every phase and assure audit-ready execution. Robust data governance, including GDPR compliance, global standards, encryption, role-based access, and validated audit trails, protects information integrity.

Coupled with Efor’s quality, regulatory, and biotox expertise, we give sponsors a single, end-to-end partner that moves healthcare products and medicines seamlessly from molecule to market.

Our Project References

Full-Service Study Support

End-to-end services from protocol to publication
Efor provided a turnkey Phase Ib solution for a biotechnology start-up focused on central nervous system disorders. Our 3.5-year engagement covered the complete study lifecycle: protocol design, start-up, clinical operations, biometrics, data analysis and publication. Acting as an integrated partner, we ensured timely enrolment, rigorous data quality and audit-ready documentation, allowing the therapy to progress smoothly along its clinical development path toward market access.
International PMCF Study

Generating data for devices already on the market
Our multidisciplinary CRO teams managed a five-year, multi-country post-market clinical follow-up (PMCF) study for an orthopedic implant manufacturer. We ensured all study phases from study design and operational setup to clinical oversight, data management, biostatistics, and final study reporting, generating post-market clinical evidence to ascertain the long-term evaluation of long-term safety and performance to meet global regulatory requirements.
Meta-Analysis Based on Multiple Clinical Trials

Improving precision, resolving uncertainties
We supported a leading vaccine manufacturer in conducting a rigorous meta-analysis involving data from multiple clinical trials. Our teams provided support across key data standardization and statistical activities, including CDISC SDTM conversion, ADaM dataset development, and integrated statistical analyses. This enabled the generation of consolidated evidence to strengthen data interpretation and support clinical development objectives.
Clinical Operations & Site Management Excellence

Seamless site execution and rigorous data oversight
Our Clinical Research Associates (CRAs) and Clinical Research Technicians (CRTs) provided comprehensive operational support for breast cancer imaging diagnostics study, including source data verification, site monitoring visits, imaging data collection and reconciliation, and coordination with participating centers. Through the management of thousands of imaging records and rigorous quality control processes, we helped ensure the reliability and completeness of the clinical dataset used to evaluate the performance of the diagnostic technology.
National Registry Study

Unified data driving insight, care, and informed decisions
We provided regulatory and project coordination support for an international registry conducted by a major cardiovascular association. Our scope included the preparation and management of regulatory submissions, coordination with ethics committees and competent authorities, and overall study governance. By ensuring alignment across stakeholders, countries, and regulatory requirements, we contributed to the timely initiation and successful execution of this key clinical development program.
End-to-End Clinical Data Management

Inspection-ready data
Our experts supported a specialized Phase I CRO across a broad portfolio of clinical studies conducted internationally. Acting as an extension of their biometrics team, we provide end-to-end Data Management services, enabling them to remain focused on their core expertise in Clinical Operations. Our support covers the full data lifecycle, from CRF design and eCRF development to database management, data review, quality control, query management, and database lock. Through this long-term collaboration, we ensure the delivery of high-quality, reliable, and inspection-ready clinical data across multiple development programs.

Outcomes for Our Clients

Our integrated model:

Accelerates every stage of your clinical trials, from first-patient-in to database lock.
Ensures inspection-ready documentation and impeccable data quality.
Reduces protocol deviations and costly rework.
Enables earlier regulatory submissions and accelerates time-to-market.
Delivers structured evidence packages that simplify future indication expansions and geographic rollouts.

Ready to convert complex clinical data
into decisive regulatory evidence?

Contact our experts to design a smarter, faster path to market.

Clinical Contract Research Organization (CRO)